What we do
OncoRadiomics develops products and services with the unique advantage
of providing higher quality care for cancer patients while minimizing total treatment cost at the same time
Decision Support for Treatment
Semi-automatic high throughput augmented clinical decision support with an accuracy on par or superior to an oncologist.
Efficient Trial Management
Speed up and reduce the cost of clinical (pharmaceutical) trials by early detection of effective drugs and (non) responders
Decision Support for Diagnosis*
Semi-automatic high throughput augmented screening with an accuracy on par or superior to a radiologist
Our mission is to enable the right diagnosis* & treatment* for the right patient through quantitative imaging and machine learning.
OncoRadiomics harnesses the power of artificial intelligence to deliver accurate and robust clinical decision support systems based on standard clinical imaging.
Revolutionizing precision medicine thanks to
the new Core Imaging Biomarker: Radiomics
Research & Clinical solutions
The Research ToolBox
The world first Automated Radiomic Feature Extractor with Automated Machine Learning.
An end to end solution created to make your radiomics research as efficient as possible.
Click to learn more
Open source research solutions exist but our Discovery ToolBox offers much more to it's user.
Automated feature extraction, secure image upload, Expert support in refining models, unique features to be extracted, Automated machine learning, autosegementation tools and much more.
News and Events
Friday 11/12/2019 - 10:00
AI4Imaging - Radiomics, Deep learning and distributed learning - a hands-on course
This course on Big Data for Imaging is a unique opportunity to join a community of leading edge practitioners in the field of Artificial Intelligence for Medical Imaging. During this 4-days immersive course, you will be able to attend lectures and workshops from world-class experts in Radiomics, Deep Learning and Distributed Learning.
22 April 2016 – AQUILAB (Lille, France) and OncoRadiomics (Maastricht, the Netherlands) announced today they have signed a collaboration agreement that will enable AQUILAB to integrate radiomics technology developed by OncoRadiomics in its ARTIVIEW imaging software solution
Send an email directly to :
*For Research Use Only.
This product is in the research phase of development and has not been demonstrated to be safe or effective for clinical use. Any use of this product and the associated information is for research only and not for a diagnostic, therapeutic or other clinical purposes.
Not clinically available (not CE marked, nor FDA cleared).